“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial
Join AIR as a Researcher focused on Marketplace, Medicaid and Medicare policy and programs with our Healthcare Transformation team to serve as a task and project leader on a broad portfolio of health policy work. Our
Join AIR as a Managing Director with our Healthcare Innovations team. Our team works collaboratively to unravel the intertwined challenges of health care quality, costs, and access. Our team of experts–economists, data scientists, statisticians, public health